WIC
DGX icon

Woodmont Investment Counsel’s Quest Diagnostics DGX Stock Holding History

Woodmont Investment Counsel’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-739
Closed -$63K – 290
2016
Q3 		$63K Buy
+739
New +$62.1K 0.02% 236
2016
Q2 		– Sell
-700
Closed -$50K – 246
2016
Q1 		$50K Hold
700
– – 0.02% 258
2015
Q4 		$50K Hold
700
– – 0.01% 262
2015
Q3 		$43K Hold
700
– – 0.01% 275
2015
Q2 		$51K Buy
+700
New +$51.7K 0.01% 258

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Woodmont Investment Counsel's DGX Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 739 shares — an estimated $63K sold.

Woodmont Investment Counsel first reported a position in DGX in Q2 2015 and held it in 5 quarters. The position peaked at $63K in Q3 2016. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 739 Quest Diagnostics shares in Q4 2016, an estimated $63K.
  • Woodmont Investment Counsel first reported a position in Quest Diagnostics in Q2 2015 and held it in 5 quarters.
  • Woodmont Investment Counsel's Quest Diagnostics position peaked at $63K in Q3 2016.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.